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Abstract: Endogenous melatonin is a known free radical scavenger that removes reactive 
oxygen species (ROS), thus, alleviating oxidative stress. The purpose of this study was to 
demonstrate its effect against kainic acid (KA)-induced oxidative stress in organotypic 
hippocampal slice cultures (OHSCs). To observe neuroprotective effects of melatonin, 
different concentrations (0.01, 0.1 and 1 mM) of melatonin were administrated after KA 
treatment for 18 h in OHSCs of rat pups. Dose-response studies showed that neuronal cell 
death was significantly reduced after 0.1 and 1 mΜ melatonin treatments based on propidium 
iodide (PI) uptake and cresyl violet staining. The dichlorofluorescein (DCF) fluorescence 
which indicates ROS formation decreased more in the melatonin-treated group than in the 
KA group. The expression of 5-lipoxigenase (5-LO) and caspase-3 were reduced in the 
melatonin-treated groups compared to the KA group. These results suggest that melatonin 
may be an effective agent against KA-induced oxidative stress in the OHSC model. 
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1. Introduction 
It is well known that the excessive production of oxygen free radicals may generate neuronal 
disorders. The brain is one of the most oxygen consuming organs [1]; therefore, reactive oxygen 
species (ROS) production in the brain is higher than in the rest of the body. In general, an antioxidant 
maintains and regulates the equilibrium between ROS formation and extinction. If the equilibrium is 
disrupted, however, ROS act as a stressor and damage intracellular elements such as proteins, lipids, 
and DNA. Because neuronal cells are especially sensitive and vulnerable to ROS, apoptosis or necrosis 
can occur easily [2]. Therefore, oxidative stress produces neurotoxicity in the brain. Specially, 
mitochondrial oxidative stress has frequently been associated with various neuronal disorders [3]. 
Melatonin is a known antioxidant secreted from various organs, including the pineal gland, retina, 
lens, and gastrointestinal tract. Melatonin plays a variety of physiological roles such as the adaptation 
of the day and night cycle, acclimation, and participation in immune reaction. Its protective effect in 
many neurodegenerative disorders (e.g., Alzheimer’s disease, Parkinson’s disease, ischemia-reperfusion 
injury, mental disorders) have also been implicated [4–7]. Because of its favorable physicochemical 
proprieties, melatonin is able to pass biological barriers such as the cellular membrane [8]. In addition, 
because it is an electron-rich molecule, melatonin produces stabilized molecules by reacting with 
various ROS. Particularly, melatonin produces stabilized molecules without generating any other ROS 
because redox cycling is not required for melatonin. Melatonin is referred to as a suicidal or terminal 
antioxidant, because the body excretes metabolites produced by melatonin, via urine, without any 
secondary influence on body tissue [9]. Melatonin binds to the membrane receptor with high affinity  
in the picomolar range, and also to the nuclear receptor as well as calmodulin in the nanomolar  
range [10]. Melatonin has a free radical scavenging function at even higher concentrations. As a result, 
melatonin acts as an antioxidant [8,11–14]. 
Kainic acid (KA) is an agonist of the ionotrophic glutamate receptor. Its action as an excitotoxin 
leads to neuronal excitotoxicity and oxidative damage in the central nervous system [15]. KA binds to 
the kainate receptor and produces neuronal death [16]. Therefore, KA has been used to study the 
neuroprotective effects of various agents against oxidative stress. 
In our previous studies, we have shown that antioxidants, such as Coenzyme Q10 and ascorbic acid, 
have elicited neuroprotective effects against KA-induced neurotoxicity in organotypic hippocampal 
slice culture (OHSC) [17–19]. The goal of the present study was to investigate the ability of melatonin 
to protect cell viability in the same in vitro model system. 
2. Results and Discussion 
2.1. Effects of Melatonin on KA-Induced Neuronal Toxicity in OHSCs 
PI uptake was used to investigate the effects of melatonin on KA-induced neuronal injury. 
Hippocampal tissues showed almost no damage in the pre-phase. The intensity of PI uptake was 
increased in the hippocampus CA1, CA3, and dentate gyrus 18 h after KA treatment. However, 
reduced intensity was shown in 0.01, 0.1, and 1 mM melatonin-treated groups compared with the KA 
only-treated group (Figure 1A). The values in % of PI uptake in the CA1 and CA3 region of the 
Int. J. Mol. Sci. 2014, 15 5942 
 
hippocampus layers are shown in Figure 1B,C. Reduced levels of PI uptake in CA1 and CA3 were 
observed in the 0.01, 0.1, and 1 mM melatonin-treated groups. 
Figure 1. Melatonin reduces KA-induced neuronal injury in organotypic hippocampal slice 
cultures (OHSCs). (A) Difference of PI uptake fluorescence intensities in KA only-treated 
group and melatonin-treated groups determined using a fluorescence microscope;  
(B,C) Quantification of PI uptake intensities using a MetaMorph program in the CA1 (B) 
and CA3 (C) regions. The horizontal axis indicates time after melatonin treatment and the 
vertical axis represents the percent of PI uptake in each region. Fluorescence values were 
calculated using the following formula: % of PI uptake = 100 × (Ft − Fpre)/(Ffk − Fpre). Data are 
mean ± SEM (n = 6). * p < 0.05, ** p < 0.01, *** p < 0.001: one-way ANOVA followed 
by a LSD test for the comparison with the KA only-treated group. Scale bar: 500 µm. 
(A) PI uptake 
(B) CA1 region (C) CA3 region 
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2.2. Cresyl Violet Staining 
Cresyl violet staining was used to detect neuronal cell survival. Normal tissue had numerous 
neuronal cells throughout all the cell layers. KA only-treated tissue had fewer cells in the layer, 
especially in the CA3 region compared with the CA1 region. More cells survived in melatonin-treated 
than in KA only-treated tissue, but this number was lower than that in normal tissue (Figure 2). 
Figure 2. Melatonin increases neuronal survival in KA-induced neuronal injury in OHSCs. 
(A) Morphology of survived cells in 10 µm dissected hippocampal tissue. The pictures 
represent normal, KA only treated, 0.01, 0.1, and 1 mM melatonin-treated groups at 48 h 
after melatonin treatment; (B,C) Quantification of cell survival using a MetaMorph 
program in CA1 (B) and CA3 (C) regions. The horizontal axis indicates treatment groups 
and the vertical axis indicates the number of cresyl violet-positive cells. Data are mean ± 
SEM (n = 6). ** p < 0.01: one-way ANOVA followed by LSD test for the comparison with 
KA only-treated group. Scale bar: 200 µm. 
(A) 
(B) CA1 region (C) CA3 region 
Treatment groups Treatment groups 
2.3. Formation of ROS in KA-Induced Oxidative Stress 
DCFH-DA fluorescence dye was used to detect ROS formation in the hippocampal tissue (Figure 3). 
ROS formation was detected from the overall cell layers. 10 μΜ dye was represented in a green 
fluorescence. Fluorescence in the tissue was minute before the KA treatment, but 5 μΜ KA generated 
fluorescence beyond normal. After melatonin treatment, the fluorescence was significantly reduced 
compared with KA-treated groups (p < 0.01). 
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Figure 3. Relationship between melatonin treatment and ROS formation. (A) DCFH-DA 
intensities in each group. DCFH-DA expression level was detected at pre, 18 h after KA 
injury, and 24 h after melatonin treated phase; (B) Quantification of DCFH-DA intensities 
using a MetaMorph program. The horizontal axis indicates pre-melatonin treatment 
(Before) and 24 h after melatonin treatment (After) and the vertical axis represents  
DCFH-DA intensity in the hippocampal tissues. Data are mean ± SEM (n = 6). ** p < 0.01: 
one-way ANOVA followed by LSD for comparison with each group. Scale bar: 500 µm. 
(A) PI uptake 
(B) 
2.4. Western Blotting 
The 5-lipoxigenase (5-LO) expression is a marker of lipid peroxidation. The KA group had higher 
5-LO expression than the other groups (Figure 4A). Twenty-four hours after melatonin treatment,  
0.1 and 1 mM of melatonin significantly reduced the 5-LO expression. Caspase-3 expression is a 
marker of apoptosis, and also plays a role in necrosis and inflammation. The normal group showed 
lower expression than the KA-treated group. The 0.01, 0.1, and 1 mM melatonin-treated groups also 
showed reduced caspase-3 expression (Figure 4B). 
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Figure 4. Western blot analysis of 5-LO and caspase-3 in OHSC after melatonin treatment 
following KA. (A) The expression of 5-LO at 24 h after the 0.1 and 1 mM melatonin-treated 
groups was significantly lower than that of the KA-treated group; (B) The level of caspase-3  
at 24 h after melatonin treatment. The 1 mM melatonin-treated group showed lower 
caspase-3 expression than KA group. The horizontal axis indicates each experimental 
group (Normal, KA, 0.01, 0.1, 1 mM) and the vertical axis represents the level of protein 
expression ratio (antibody expression/α-tubulin expression). Data are mean ± SEM. * p < 0.05: 
one-way ANOVA followed by an LSD test. 
(A) (B) 
 
 
Treatment groups Treatment groups 
2.5. Discussion 
It has been previously shown that KA generates ROS in the brain [20,21]. Recently, some studies 
have demonstrated that melatonin may attenuate brain injury through its antioxidant effect. According 
to Juliana et al. [22], amyloid-ß neurotoxicity was reduced by melatonin in organotypic culture. It has 
also been shown that the administration of melatonin in rats attenuates oxidative stress-induced 
neurodegeneration and microglial generation [23]. Especially, Zaja-Milatovic et al. [20] have noticed 
that MT1A and MT1B receptors are abundant in the CA1 and CA3 region of the hippocampus which 
regulates the activation of melatonin. 
In our study, to demonstrate the antioxidant effects of melatonin, the KA-induced oxidative stress 
model was chosen because the KA-induced injury is more effective in the hippocampal CA3 region 
than CA1 which makes it easy to specify an injury model [24–26]. There was no PI uptake observed at 
different concentrations (0.01–1 mM) of melatonin alone in the OHSC (data not shown). This study 
would be a valuable support for previous studies related to antioxidant effects of melatonin on  
KA-induced oxidative stress. The results demonstrated that melatonin effectively suppresses neuronal 
cell death in CA1 and CA3 regions in the hippocampus, based on measurement of PI uptake. 
The DCFH-DA method is widely used in ROS measurement in the mitochondria. It is a major 
advantage of DCFH-DA that it detects both mitochondria and live cells [27]. The results from 
fluorescence measurements using DCFH-DA demonstrated the association between neuronal death 
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and ROS. We also found a relationship between PI and cresyl violet staining. Unlike the ROS 
generation, the results from PI uptake and cresyl violet staining were dependent on melatonin 
concentration, which increased as the concentration of melatonin increased. 
According to Flavia et al. [28], KA-induced damage showed up-regulation of 5-LO expression in 
limbic system. In addition, increased endogenous ROS up-regulated 5-LO expression. The generation 
of the endogenous ROS by antimycin A increases up-regulation of 5-LO activity three-fold [29]. 
Apoptotic neuronal death with KA injury induces rapid induction of bax, collapse of mitochondrial 
membrane potential, release of cytochrome c from mitochondria, and activation of caspase-3, 
suggesting that multiple apoptotic pathways are activated in response to KA [30]. Caspase-3 
participates in various apoptosis pathways including KA-induced injury. From our study, melatonin 
gradually reduced caspase-3 activity, especially, that 1 mM melatonin significantly attenuated in 
caspase-3 expression. This finding indicates that melatonin has neuroprotective effects that regulate 
viability of cells against ROS and apoptosis. Several studies have demonstrated that antioxidants  
can attenuate KA-induced neuronal damage [31,32]. Especially, mitochondria superoxide radical 
production generates ROS and hippocampus destruction demonstrated that the oxygen free radical was 
generated in the limbic structure by KA-induced seizures, and another study demonstrated that  
KA-induced damage in neuron generated a mitochondrial superoxide production [20,23,33]. 
Taken together, this study demonstrated the effect of melatonin on KA-induced oxidative damage 
using different concentrations of melatonin. Treatment with melatonin significantly attenuated 
neuronal damage and the generation of ROS. Higher concentrations of melatonin were more effective 
than that of lower concentrations. These results suggest that melatonin could be an effective 
antioxidant in the context of oxidative stress. 
3. Experimental Section 
3.1. Organotypic Hippocampal Slice Culture (OHSC) 
All animal experiments were approved by the Institutional Animal Care and Use Committee of 
Yonsei University Health System. OHSC was conducted in accordance with our previous experimental 
protocols [16–18] modified from Stoppini et al. [34]. In brief, the brains of 6–8 day-old Sprague-Dawley 
rats (Koatech, Gyeonggi-do, Korea) were removed and transferred to Gey’s Balanced Salt Solution 
(GBSS, Sigma, St. Louis, MO, USA) containing 0.5% glucose and 3 mM KCl, 1 N HCl. Rat 
hippocampi were separated from the whole brains and then dissected to 350 µm with a McIlwain 
tissue chopper (Vibratome, O’Fallon, MO, USA). Undamaged and clear layered dissected tissues were 
selected. Six to eight tissues were transferred onto a Millicell-CM membrane insert (Millipore, 
Billerica, MA, USA) in 6-well plate containing 1 mL culture media (pH 7.2) composed of 50%  
Opti-MEM, 25% Hank’s Balanced salt solution (HBSS), 25% heat inactivated horse serum (all from 
GIBCO BRL, Grand Island, NY, USA), and 6.5 mg/mL D-glucose (AMRESCO Inc., Solon, OH, 
USA). Cultured slices were incubated at 36 °C in a humidified atmosphere of 5% CO2. Culture media 
was changed three times a week. Slices were grown for 3 weeks in the culture medium. 
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3.2. Drug Preparation and Treatment 
Five micro moles per liter kainic acid (KA, K0250, Sigma, St. Louis, MO, USA) was dissolved in 
DW and applied to cultured slices for 18 h in OHSC. Melatonin (Sigma) was dissolved in ethanol 
(Merk, Darmstadt, Germany) then diluted and treated with culture medium at 0.01, 0.1, and 1 mM 
concentrations. Afterwards, KA-injured hippocampal slices were kept on melatonin for 24 and 48 h. 
The experimental procedure is shown in Figure 5. 
Figure 5. Diagram of the experimental procedure. OHSCs was cultured for three weeks 
and 5 µg/mL PI was treated in the culture medium (pre-phase, Pre). After 1 h, the pictures 
of pre-phase cultured hippocampus were taken. Then, 10 μΜ DCFH-DA was treated for  
30 min and DCFH-DA picture was taken. KA was diluted and treated with fresh culture 
medium for 18 h. DCFH-DA pictures were taken in this phase but not PI uptake. 
Subsequently, melatonin-treated hippocampus pictures of 24 and 48 h after melatonin 
treatment for PI and 24 h DCFH-DA were gathered. 
 
3.3. Measurement of Neuronal Injury 
To observe neuronal cell death, we used propidium iodide (PI, Sigma, St. Louis, MO, USA) 
staining. Three weeks after OHSCs, cultured normal hippocampal slices were added with 5 μM PI in 
culture medium and detected the neuronal death in the pre-phase which has no PI uptake in the 
hippocampal layers. After KA treatment for 18 h, degenerated tissue was removed from the membrane 
insert and PI uptake was monitored. Effects of 0.01, 0.1, and 1 mM melatonin treatment for 24 and 48 h 
were observed by PI. Full kill was performed with 10 mM NMDA (Sigma) to produce neuronal death 
in all tissue areas. Finally, pre, 24 h, 48 h, and full-kill phase results were detected by the fluorescence 
microscope and analyzed with a MetaMorph program (Universal Imaging, Downingtown, PA, USA). 
All values of the fluorescence were calculated using the following formula: % of PI uptake = (Ft − Fpre)/ 
(Ffk − Fpre) × 100 (Ft = PI uptake at 24 or 48 h after melatonin treatment, Fpre = pre, Ffk = full kill). 
3.4. Evaluation of Intracellular ROS Formation 
Tissues were incubated with 10 μΜ 2',7'-dichlorohydrofluorescein diacetate (DCFH-DA, Sigma)  
in a 36 °C humidified incubator for 30 min and washed twice with phosphate-buffered saline, pH 7.4 
(1× dPBS, GIBCO, Grand Island, NY, USA). DCFH-DA expression level was detected at pre,  
Fluorescence detect with 
Fluorescence detect with DCFH-DA
Culture 
start 
KA treatment (10 μM for 18 h) 
Melatonin treatment (24 and 48 h after) 
Pre After 24 h After 48 h 
18 h3 w
Drug treatment Western 
Cresyl violet 
Western
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18 h after KA injury and 24 h after melatonin treatment using a fluorescence microscope  
(IX-71, Olympus, Tokyo, Japan). The DCFH-DA fluorescence intensity was measured by a 
MetaMorph program (Universal Imaging). 
3.5. Cresyl Violet Staining 
To detect the survival of cells using the cresyl violet staining, each slide was soaked in 4% 
paraformaldehyde (Duksan, Incheon, Korea) for 20 min, washed out twice with 1× dPBS, soaked into 
cresyl violet solution (Sigma), and washed with flowing tap water. The tissue sections were dehydrated 
with 70%, 90%, and 100% EtOH (Ducksan), soaked into the 50:50 (EtOH and xylene) mixture, and 
stored in 100% xylene (Ducksan). Finally the slides were mounted with permount. The MetaMorph 
program was used to detect the survived neurons in CA3. 
3.6. Western Blot Analysis 
Cultured slices were collected and homogenized with lysis buffer containing 10% SDS, 1 M Tris–HCl 
(pH 7.4), 5% Triton X-100, 50% sodium deoxycholate, 1 M DTT, 0.5 M sodium orthovanadate,  
2 mg/mL PMSF, 10× protease inhibitor (all from Sigma). The homogenized solution was frozen  
and thawed in −80 °C three times. Proteins were separated by SDS-PAGE, and transferred to a 
nitrocellulose membrane (Millipore, Billerica, MA, USA). The membrane was blocked by 5% skim 
milk in Tris-buffered saline added with 0.5% Tween-20, and was incubated with primary antibodies 
(5-LO, Cayman, Ann Arbor, MI, USA; caspase-3, Santacruz Biotechnology, Santa Cruz, CA, USA;  
β-actin, Abcam, Cambridge, UK) overnight at 4 °C. The membrane was developed with a  
peroxidase-conjugated secondary anti body, and protein was detected by enhanced chemiluminescence 
(ECL) procedure (Amersham, Arlington, IL, USA). 
3.7. Statistical Analysis 
All data were expressed as mean ± SEM. Differences among groups were analyzed by LSD  
post-hoc test. The level of significance was accepted at * p < 0.05, ** p < 0.01 and *** p < 0.001. 
4. Conclusions 
The present study used PI, cresyl violet, and DCFH-DA fluorescence staining to demonstrate that 
KA-induced injury is related to generation of ROS, which has a neurotoxic effect in the hippocampus. 
We found that melatonin reduced ROS generation and neuronal cell death. This suggests that 
melatonin has neuroprotective effects on KA-induced oxidative stress in the hippocampus as an 
antioxidant. Melatonin may therefore be important for alleviating neuronal disorders that can be 
generated by oxidative stress. 
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